Corporate Presentations
Latest Summary Corporate Presentation
View Presentation-
13 Sep 2022
Company presentation: Xanamem® Clinical Program Update – Alzheimer’s Disease (AD) biomarkers – context and history
-
11 Aug 2022
Company presentation: CEO presentation for non-deal roadshow investor meetings
-
03 Aug 2022
Webcast video recording: Actinogen Clinical Trials Science Forum
-
03 Aug 2022
Company presentation: Actinogen Clinical Trials Science Forum
-
28 Jul 2022
Company presentation: CEO presentation to Spark Plus Australian Equities Day
-
14 Jun 2022
Company presentation: CEO presentation for meetings at BIO International Convention
-
11 May 2022
Company presentation: Bioshares Biotech Summit 2022
-
04 May 2022
Company presentation: ACW trial results & strategic update presentation
-
27 Apr 2022
Webcast video recording: XanaMIA Part A Trial positive topline results for Xanamem
-
27 Apr 2022
Company presentation: XanaMIA Part A Trial positive topline results for Xanamem
2023 Annual General Meeting
Actinogen’s next Annual General Meeting
Date: November 2023 (TBA)
Read more